H. T. Cao, T. Roisnel, A. Valleix, R. Grée
FULL PAPER
dioxane (2 mL) . The reaction mixture was stirred overnight at
room temperature and then extracted with pentane (3ϫ5 mL) to
remove byproducts. After addition of a saturated aqueous solution
of NaHCO3 (up to pH = 8), the reaction mixture was extracted
7.1 Hz, 1 H, CHCH3), 1.69–1.31 [m, 8 H, (CH2)4CH3), 1.28 [s, 9
H, (CH3)3SO], 0.89 [t, J = 6.6 Hz, 3 H, (CH2)4CH3], 0.81 (d, J =
7.1 Hz, 3 H, CHCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 11.2,
14.1, 22.6, 22.7, 25.7, 31.9, 34.9, 44.8, 55.7, 58.6, 74.3, 126.8, 127.2,
with EtOAc (3ϫ5 mL). The organic extracts were combined, dried 128.1, 142.0 ppm. HRMS: calcd. for C19H33NO2NaS [M + Na]+
(Na2SO4), and concentrated under vacuum to afford pure β-amino
ketone 5a as a colorless oil (36.5 mg, 98%). H NMR (300 MHz,
362.21297; found 362.2132. C19H33NO2S: calcd. C 67.21, H 9.80,
1
N 4.13, S 9.44; found C 67.34, H 9.79, N 4.03, S 9.13. [α]1D8 = +97.5
CDCl3): δ = 7.27–7.17 (m, 5H, HAr), 4.16 (d, J = 6.7 Hz, 1 H, (c = 0.0011, CHCl3).
CHC6H5), 2.78 (qt, J = 6.9 Hz, 1 H, CHCH3), 2.25 (td, J = 7.5, J
Synthesis of ent-Nikkomycin Precursor
= 17.1 Hz, 1 H, CH2CO), 2.06 (td, J = 7.5, J = 17.1 Hz, 1 H,
CH2CO), 1.34 (qt, J = 7.0 Hz, 2 H, CH2CH2CO), 1.24–1.01 [m,
7H, CH3CH, (CH2)2CH3], 0.79 (t, J = 7.1 Hz, 3 H, CH2CH3) ppm.
13C NMR (75 MHz, CDCl3): δ = 12.1, 13.9, 22.4, 23.0, 31.2, 42.6,
53.8, 57.1, 126.7, 127.2, 127.6, 128.4, 128.5, 144.1, 214.0 ppm.
HRMS: calcd. for C14H20NO [M – CH3]+ 218.15449; found
218.1538. [α]1D9 = –66.7 (c = 0.0055, CHCl3). Chiral HPLC: column,
CHIRALPAK AD 250*4.6, eluent hexane/EtOH, 90:10,
1.2 mLminϪ1, retention times for (Ϯ)-5a: 7.2 and 8.5 min. 5a: re-
tention time 7.2 min, ee Ն 99%.
Step 1. Synthesis of 19 and 20: Same procedure as that used for 3a/
4a: [NiCl2(dppe)] (480 mg, 0.91 mmol) in THF (15 mL); 1 m solu-
tion of LiBHEt3 in THF (910 μL, 0.91 mmol); MgBr2 (170 mg,
0.0.91 mmol); sulfinyl imine 17 (930 mg, 4.54 mmol) in THF
(3 mL) and a solution of allylic alcohol 18 (1.49 g, 9.1 mmol) in
THF (5 mL). The two diastereoisomers 19 and 20 were isolated as
colorless solids in 96% yield (1.72 g).
Isomer syn-19: 1.55 g; m.p. 120–122 °C. Rf = 0.30. 1H NMR
(300 MHz, CDCl3): δ = 7.94 (d, J = 8.9 Hz, 2 H, HAr), 6.93 (d, J
= 8.9 Hz, 2 H, HAr), 4.34–3.95 (m, 5 H, NH, CHNH, CHCH3,
CH2CH3), 3.86 (s, 3 H, OCH3), 1.35 (d, J = 7.2 Hz, 3 H, CHCH3),
1.21 [s, 9 H, C(CH3)3], 1.19 (t, J = 6.9 Hz, 3 H, CH2CH3) ppm.
13C NMR (75 MHz, CDCl3): δ = 13.9, 14.8, 22.3, 43.2, 55.4, 56.5,
60.3, 61.4 113.9, 128.4, 130.7, 163.7, 171.4, 200.1 ppm. HRMS:
calcd. for C18H27NO5NaS [M + Na]+ 392.15021; found 392.1505.
[α]1D6 = +55.9 (c = 0.0145, CHCl3).
Isomer anti-20: 170 mg; m.p. 128–130 °C. Rf = 0.35. 1H NMR
(300 MHz, CDCl3): δ = 7.92 (d, J = 9.0 Hz, 2 H, HAr), 6.94 (d, J
= 9.0 Hz, 2 H, HAr), 4.96 (d, J = 9.0 Hz, 1 H, NH), 4.16–4.06 (m,
4 H, CHNH, CHCH3, CH2CH3), 3.86 (s, 3 H, OCH3), 1.38 (d, J
= 7.0 Hz, 3 H, CHCH3), 1.26 [s, 9 H, C(CH3)3], 1.17 (t, J = 7.1 Hz,
3 H, CH2CH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.9, 15.4,
22.5, 42.0, 55.4, 56.7, 61.4, 61.8, 113.9, 128.7, 130.7, 163.8, 171.7,
6a: Same procedure as that used for 5a: Compound 4a (87 mg,
0.26 mmol) in 1,4-dioxane (3 mL) was treated with a 1 m solution
of HCl (3 mL, 0.3 mmol). Isomer anti-6a was isolated as a colorless
1
oil (58 mg; 97%). H NMR (300 MHz, CDCl3): δ = 7.26–7.20 (m,
5H, HAr), 4.00 (d, J = 9.3 Hz, 1 H, CHC6H5), 2.79–2.69 (m, 1 H,
CHCH3), 2.53–2.30 (m, 2 H, CH2CO), 1.62 (br. s, 2 H, NH2) 1.51
(qt, J = 7.1 Hz, 2 H, CH2CH2CO), 1.26–1.17 [m, 4 H, (CH2)2CH3],
0.81 (t, J = 7.1 Hz, 3 H, CH2CH3), 0.76 (d, J = 7.1 Hz, 3 H,
CHCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.9, 15.2, 22.4,
23.1, 31.4, 42.8, 54.1, 58.8, 127.0, 127.4, 128.5, 128.6, 143.9, 215.2
ppm. HRMS: calcd. for C14H20NO [M – CH3]+ 218.15449; found
218.1538. [α]1D9 = +57.3 (c = 0.0030, CHCl3). Chiral HPLC: col-
umn, CHIRALPAK AD 250*4.6, eluent hexane/EtOH, 95:5,
1.2 mLminϪ1, retention times for (Ϯ)-6a: 7.3 and 9.4 min. 6a: re-
tention time 7.3 min, ee Ն 99%.
201.5 ppm. HRMS: calcd. for C18H27NO5NaS [M
+
Na]+
392.15021; found 392.1504. [α]1D6 = +55.6 (c = 0.0068, CHCl3).
Reduction Using NaBH4. Synthesis of 7a and 8a as Representative
Examples: NaBH4 (35 mg, 0.85 mmol) was added in 3 portions,
under nitrogen at 0 °C, to a solution of β-amino ketone 3a (190 mg,
0.56 mmol) in MeOH (6 mL) . The reaction mixture was kept un-
der magnetic stirring at 0 °C until the starting material disappeared
(TLC monitoring, about 1 h). After addition of water (10 mL) and
extraction with EtOAc (3ϫ10 mL), the organic phases were com-
bined, washed with a saturated solution aqueous of NaCl, dried
(Na2SO4), and concentrated under vacuum. The crude product was
purified by chromatography on SiO2 by using a 1:1 mixture of n-
pentane and EtOAc as the eluent. The two diastereoisomers 7a and
8a were obtained in a ratio of 55:45, as determined by 1H NMR
spectroscopy, and isolated in 95% overall yield (180 mg).
Step 2. Synthesis of Compounds 21 and 22: NaBH4 (70 mg,
1.8 mmol) was added in three portions, under nitrogen at 0 °C, to
a solution of β-amino ketone 19 (328 mg, 0.89 mmol) and BnBr
(0.43 mL, 3.6 mmol) in MeOH (10 mL). The reaction mixture was
kept under magnetic stirring at 0 °C until the starting material dis-
appeared (monitoring by TLC, about 1 h). After addition of water
(15 mL) and extraction with EtOAc (3ϫ15 mL), the organic
phases were combined, washed with a saturated aqueous solution
of NaCl, dried (Na2SO4), and concentrated under vacuum. The
crude product was purified by chromatography on SiO2 by using a
4:6 mixture of n-pentane and EtOAc as the eluent. The two dia-
stereoisomers 21 and 22 were obtained in a ratio of 67:33, as deter-
mined by 1H NMR spectroscopy, and isolated as colorless solids
in 91% overall yield (163 mg).
Isomer anti–anti-21: 109 mg; m.p. 110–112 °C. Rf = 0.46. 1H NMR
(300 MHz, CDCl3): δ = 7.27 (d, J = 8.7 Hz, 2 H, HAr), 6.91 (d, J
= 8.7 Hz, 2 H, HAr), 4.38 (d, J = 10.0 Hz, 1 H, CHCO), 3.93 (dd,
J = 8.0, J = 11.0 Hz, 1 H, CHNH), 3.82 (s, 3 H, OCH3), 3.79 (d,
J = 8.0 Hz, 1 H, NH), 2.34 (ddq, J = 6.4, J = 10.0, J = 11.0 Hz, 1
H, CHCH3), 1.30 [s, 9 H, C(CH3)3], 1.29 (d, J = 6.4 Hz, 3 H,
CHCH3) ppm. 13C NMR (75 MHz, CDCl3): δ = 13.3, 22.5, 47.7,
55.3, 57.0, 63.4, 84.4, 114.1, 128.1, 160.2, 174.1 ppm. HRMS:
calcd. for C16H23NO4NaS [M + Na]+ 348.1240; found 348.1241.
[α]1D6 = +30.0 (c = 0.005, CHCl3).
Isomer syn–syn-7a: 99 mg; m.p. 116–118 °C. Rf = 0.22. 1H NMR
(300 MHz, CDCl3): δ = 7.36–7.25 (m, 5 H, HAr), 5.12 (d, J =
2.1 Hz, 1 H, NH), 4.70 (t, J = 2.5 Hz, 1 H, CHC6H5), 4.04 (dd, J
= 4.0, J = 7.8 Hz, 1 H, CHOH), 3.65 (br. s, 1 H, OH), 1.84 (ddq,
J = 1.5, J = 3.0, J = 7.1 Hz, 1 H, CHCH3), 1.58–1.22 [m, 17 H,
(CH2)4CH3, (CH3)3SO], 0.89 [t, J = 6.8 Hz, 3 H, (CH2)4CH3], 0.85
(d, J = 7.1 Hz, 3 H, CHCH3) ppm. 13C NMR (75 MHz, CDCl3):
δ = 4.8, 14.0, 22.6, 22.7, 25.8, 31.8, 36.0, 44.0, 55.6, 63.3, 75.6,
127.0, 127.4, 128.1, 142.1 ppm. HRMS: calcd. for C19H33NO2NaS
[M + Na]+ 362.21297; found 362.2133. [α]1D8 = + 117.6, (c 0.0098,
CHCl3).
1
Isomer syn–anti-8a: 81 mg; m.p. 120–122 °C. Rf = 0.37. H NMR
1
(300 MHz, CDCl3): δ = 7.37–7.23 (m, 5 H, HAr), 4.93 (t, J = Isomer anti–syn-22: 54 mg; m.p. 114–116 °C. Rf = 0.43. H NMR
3.5 Hz, 1 H, CHC6H5), 4.46 (d, J = 4.4 Hz, 1 H, NH), 3.56–3.50 (300 MHz, CDCl3): δ = 7.06 (d, J = 8.7 Hz, 2 H, HAr), 6.92 (d, J
(m, 1 H, CHOH), 3.30 (br. s, 1 H, OH), 1.97 (dqt, J = 3.1, J =
= 8.7 Hz, 2 H, HAr), 5.55 (d, J = 8.0 Hz, 1 H, CHCO), 3.91 (dd, J
3434
www.eurjoc.org
© 2011 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2011, 3430–3436